Chat IA
Loading data for TCRT — first visit, this takes a few seconds.

Alaunos Therapeutics, Inc.

TCRT · NasdaqCM · USD

1.49 -0.02 (-1.32%)

Al cierre: Sep 14, 2026, 8:00 PM

Volumen
9.51K

Alaunos Therapeutics, Inc. (TCRT): cotización, análisis y datos

Valor intrínseco

Cargando valor intrínseco…

Pronóstico del analista

Previsiones bursátiles →

Previsión de analistas no disponible

Objetivo a 12 meses · n/a analistas

Consenso de analistas: n/a

Intervalo:1D
Cargando velas y señales…

Desempeño financiero

Ver finanzas →

Cargando...

Últimos resultados

ReportadoVs. estimaciónCambio interanual
Ingresos$0n/an/a
EPS-$17,09-$12,59-184.83%

Próximos resultados

después del cierre del mercado.

Estimar · Actualizar →

Ver detalles de resultados →

Métricas

Precio de compra
1.24
Beneficio neto (TTM)
-4.12M
-0.97
-1.75
n/a
-2.48
P/B (TTM)
2.75
P/S (TTM)
1261.77
Fecha de resultados
Aug 14, 2025
Precio de venta
1.7
Volumen
9,512
Volumen medio (20D)
12,327
Abierto
1.49
Anterior Cerrar
1.51
Rango del día
1.49 - 1.53
Rango de 52 semanas
1.49 - 4.59
Fecha ex dividendo
n/a

Acerca de Alaunos Therapeutics, Inc.

Ver perfil →
Alaunos Therapeutics, Inc., a pre-clinical stage biopharmaceutical company that develops orally administered small-molecule therapeutics for the treatment of obesity and related metabolic disorders. It develops non-hormonal, non-incretin approach, and unlike hormone-based treatments, such as GLP-1 drugs. The company also develops hunTR TCR discovery platform to target driver mutations. Alaunos Therapeutics, Inc. was founded in 2003 and is based in Fort Lauderdale, Florida. Biotechnology · Healthcare

Alaunos Therapeutics, Inc., a pre-clinical stage biopharmaceutical company that develops orally administered small-molecule therapeutics for the treatment of obesity and related metabolic disorders. It develops non-hormonal, non-incretin approach, and unlike hormone-based treatments, such as GLP-1 drugs. The company also develops hunTR TCR discovery platform to target driver mutations. Alaunos Therapeutics, Inc. was founded in 2003 and is based in Fort Lauderdale, Florida.

Industria Biotechnology
Sector Healthcare
IPO Fecha Aug 24, 2005
Empleados 1
Bolsa de Valores NasdaqCM
Símbolo bursátil TCRT